Ryan, Elizabeth P.

Immune evasion in cancer: mechanistic basis and therapeutic strategies

Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 1,625

Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults

Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P. (2013) · PLoS ONE

Gut microbiota and healthMetabolomics and Mass Spectrometry Studies

Cited by 642

Environmental immune disruptors, inflammation and cancer risk

Thompson, P. A., Khatami, M., Baglole, C. J., Sun, J., Harris, S. A., Moon, E.-Y., Al-Mulla, F., Al-Temaimi, R., Brown, D. G., Colacci, A. M., et al. (2015) · Carcinogenesis

Immunotoxicology and immune responsesEffects and risks of endocrine disrupting chemicals

Cited by 227

Activated Human B Lymphocytes Express Cyclooxygenase-2 and Cyclooxygenase Inhibitors Attenuate Antibody Production

Ryan, E. P., Pollack, S. J., Murant, T. I., Bernstein, S. H., Felgar, R. E., & Phipps, R. P. (2005) · The Journal of Immunology

Inflammatory mediators and NSAID effectsT-cell and B-cell Immunology

Cited by 101